T cell-mediated tumor death relies on complex mechanisms and cell-cell interactions, making the development of T cell-based therapies inherently challenging. Understanding T cell differentiation and function is critical for teasing apart the complexity of the tumor microenvironment, however, T cells are exceedingly heterogeneous in both phenotype and function and have variable responses to stimulation.
Download FileOpto® B Discovery on the Beacon® optofluidic system enables rapid selection of lead candidates by function-forward screening of B cells in under 1 week. This presentation will introduce Berkeley Lights’ newest antibody discovery workflow, the Opto® Memory B Discovery workflow, and share how customers are using the workflow to screen rabbit memory B cells to rapidly discover rabbit monoclonal antibodies (as presented at Antibody Engineering & Therapeutics 2023).
Learn more about the Opto™ Antigen Presenting Bead (Opto™ APB) Kit, its key applications, and how it benefits your cell therapy development workflows by efficiently expanding more antigen-specific T cells than dendritic cells.